MedTrace Logo

Evaluation and Comparison of Several Point-of-care Platelet Function Tests in Predicting Clinical Outcomes in Clopidogrel Pre-treated Patients Undergoing Elective PCI.

NCT00352014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-04-11

No results posted yet for this study

Summary

The purpose of this study is to investigate whether the level of Platelet Inhibition as assessed with five point-of-care platelet function assays correlates with clinical (periprocedural) outcomes such as Acute Myocardial Infarction, death, Target Vessel revascularization and/or stroke in patients undergoing elective PCI.

Conditions

  • Stable Angina Pectoris

Sponsors & Collaborators

  • R&D Cardiologie

    lead OTHER

Principal Investigators

  • Jurrien M ten Berg, MD, PhD · Department of Cardiology, St. Antonius Hospital Nieuwegein, The Netherlands

  • Jochem W van Werkum, MD · Department of Research and Development in Cardiology, St. Antonius Hospital Nieuwegein, The Netherlands

  • Christian M Hackeng, PhD · Department of Clinical Chemistry, Nieuwegein, St. Antonius Hospital The Netherlands

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00352014 on ClinicalTrials.gov